Progenity Announces Expansion of Board of Directors
Company Focused on Diagnostic and Therapeutic Precision Medicine Solutions in
“Our pipeline of diagnostic and therapeutic applications under development continues to grow with innovative solutions aimed at transforming prenatal, perinatal, and gastrointestinal healthcare,” said
Progenity’s pipeline of precision medicine solutions under development includes novel products for noninvasive prenatal screening for monogenic diseases, and assays related to preeclampsia, preterm birth, oncology, and others.
These new appointees join
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20190221006043/en/
Media Contact
[email protected]
(858) 457-2436
Investor Contact
[email protected]
Source:
Sirius International Insurance: 4Q Earnings Snapshot
Flooding could lead to state of emergency
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News